Ulta Beauty, Inc. — Form 10-Q Summary
Reporting period: The supplied filing is for the 13 and 39 weeks ended October 29, 2022 (fiscal 2022 third quarter), compared with periods ended October 30, 2021. This differs from the request metadata identifying 2021 Q3. Dollar amounts below are in millions unless stated otherwise.
Business context and results
Ulta Beauty operates beauty retail stores, e-commerce and salons. It had 1,343 stores in 50 states at quarter-end, versus 1,302 a year earlier. The business is seasonal, with significant sales and profit typically generated in the holiday fourth quarter.
| Metric | Q3 FY2022 | Q3 FY2021 | 39 weeks FY2022 | 39 weeks FY2021 |
|---|---|---|---|---|
| Net sales | $2,338.8 | $1,995.8 | $6,981.8 | $5,901.5 |
| Gross profit | $962.8 | $789.5 | $2,832.0 | $2,341.2 |
| Operating income | $361.9 | $284.2 | $1,191.0 | $921.9 |
| Net income | $274.6 | $215.3 | $901.7 | $696.5 |
| Diluted EPS | $5.34 | $3.94 | $17.35 | $12.60 |
| Gross margin | 41.2% | 39.6% | 40.6% | 39.7% |
| Operating margin | 15.5% | 14.2% | 17.1% | 15.6% |
| Net margin | 11.7% | 10.8% | 12.9% | 11.8% |
Cash flow, liquidity and capital
- For the 39 weeks, operating cash flow was $573.4 million, investing cash outflow was $207.0 million, and financing cash outflow was $547.3 million. Capital expenditures were $204.0 million, versus $108.4 million a year earlier.
- Cash and cash equivalents were $250.6 million at October 29, 2022, down from $605.1 million a year earlier. Merchandise inventory was $2,114.7 million, up 10.3% year over year. Management attributed the inventory increase to brand launches, 41 net new stores, and higher inventory costs and receipts.
- No borrowings were outstanding under the $1.0 billion asset-based revolving credit facility; the company reported covenant compliance. The facility matures in March 2025. Total operating lease liabilities were $1,897.0 million; these are lease obligations, not credit-facility borrowings.
- The company repurchased $571.9 million of shares during the 39 weeks, compared with $762.2 million in the prior-year period. A $2.0 billion repurchase authorization was established in March 2022; approximately $1.4 billion remained available at quarter-end.
Material changes and management commentary
- Q3 sales rose 17.2% and net income rose 27.5% year over year. Comparable sales increased 14.6%, comprising 10.7% higher transactions and 3.5% higher average ticket. For the 39 weeks, sales increased 18.3%, net income increased 29.5%, and comparable sales rose 15.6%.
- Management attributed sales growth to beauty-category resilience, price increases, new brands and product innovation, and—in the year-to-date comparison—the easing of COVID-19 restrictions. Q3 gross-margin improvement reflected fixed-cost leverage, growth in other revenue and higher merchandise margin, partly offset by higher inventory shrink. Year-to-date margin also benefited from favorable channel mix, while lower merchandise margin and shrink were offsets.
- SG&A as a share of sales increased to 25.5% in Q3 from 25.2%, reflecting store payroll and benefits and strategic investments, partly offset by lower marketing expense. Year to date it declined to 23.4% from 23.9%, primarily due to lower marketing expense.
- Management said inflation had not materially affected sales year to date, but warned that continued inflation could pressure consumer spending, margins and operating costs. The filing provides no specific numerical earnings or sales guidance; management said current liquidity sources were expected to meet short- and long-term cash requirements.
Risks, contingencies and unusual items
- Risks cited include weaker consumer spending, inflation and higher costs, competition and changing beauty preferences, COVID-19 or other disruptions, supply-chain and fulfillment capacity, cybersecurity and information-system disruption, and execution of growth and strategic initiatives. Management noted results may be affected by pandemic developments, geopolitical events and inflationary pressures.
- The company implemented the first phase of a multi-year ERP upgrade, including a new general ledger, during Q3. Management said disclosure controls were effective and will continue monitoring controls under the new system.
- Ulta is involved in routine legal proceedings; management did not expect their outcomes to materially affect financial position, results or cash flows. The filing reported no material changes to previously disclosed risk factors.
- The Inflation Reduction Act’s corporate alternative minimum tax and excise tax on share repurchases were not expected to materially affect the consolidated financial statements. No material unusual charges are identified in the supplied filing text.
Important facts for investors to verify
- Confirm the period: the filing covers Q3 FY2022, not Q3 FY2021.
- Assess whether sales and comparable-sales growth, including price and transaction contributions, can continue after strong prior-year comparisons.
- Monitor inventory levels, shrink, merchandise margins and holiday-season demand, given the seasonal working-capital build.
- Track cash use for capital investment and buybacks, and the impact of the ERP rollout and other strategic investments on expenses and controls.
- Review the full 10-K and subsequent filings for detailed risks, commitments, lease obligations and any updated outlook; this 10-Q provides no specific numerical guidance.